Cargill and Calysta, along with several third party institutions, announced plans in November 2016 to invest in the creation of the world’s largest gas fermentation facility in Memphis, Tenn. The facility will produce Calysta’s FeedKind® protein, a family of sustainable, traceable nutritional ingredients for fish, livestock and pets.
The new venture plans to build and operate the facility on Cargill’s 69-acre property on President’s Island where Cargill currently produces corn oil and stores and distributes sweetener products. The facility is expected to come online in late 2018, producing up to 20,000 metric tons per year of FeedKind® protein initially and expanding up to 200,000 metric tons per year when operating at full capacity. Upon completion of the plant, the new venture expects to hire 75 permanent employees and expand to 160 people when the plant is at full ramp-up.
Calysta and NatureWorks (www.natureworksllc.com) have an R&D collaboration to transform methane into the lactic acid building block for bioplastics. It was announced on June 18, 2013. The companies have an exclusive, multi-year collaboration to research and develop a practical, world-scale production process for fermenting methane ̶ a potent greenhouse gas (GHG) ̶ into lactic acid, the building block for NatureWorks’ Ingeo™, lactide intermediates and polymers made from renewable materials. If the collaboration results in the successful commercialization of this first-of-its-kind technology, the cost to produce Ingeo would be structurally lowered, and the wide range of Ingeo based consumer and industrial products could be produced from an even broader set of carbon-based feedstocks, complementary to what is already in use by NatureWorks. Read more.